Van Ewyk, Michelle
Van Ewyk, Michelle was paid $478K by Medicaid between Sep 2022 and Dec 2024, across 43 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoVAN EWYK, MICHELLE
BLOOMINGDALE, IL 60108
BLOOMINGDALE, IL 60108
33aNPI1013491059assigned 09/15/2018
33bProvider typeRegistered Nurse
28Total paid$478K
24GClaims9,890
24DCodes billed43
24AFirst – last monthSep 2022 – Dec 2024
Compared with peers
Next to other Registered Nurse providers in Illinois
Rank by total paid#18 of 486
Median peer was paid$19K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 619 | $27K | |
| 2023 | 5,479 | $230K | |
| 2024incomplete | 3,792 | $221K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 3,000 | 2,595 | $160K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 12% | 167 | 95 | $56K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.3% | 388 | 314 | $30K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.4% | 354 | 337 | $26K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.6% | 317 | 250 | $22K |
| 96127 | 4.2% | 854 | 816 | $20K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.2% | 439 | 421 | $20K |
| 99384 | 3.8% | 178 | 175 | $18K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.6% | 209 | 201 | $17K |
| 99383 | 3.2% | 163 | 161 | $15K | |
| 90671 | 2.6% | 109 | 69 | $12K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 712 | 639 | $11K |
31 more codes
| 87631 | 1.5% | 68 | $7K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 175 | $6K |
| 90698 | 1.2% | 352 | $6K | |
| 90651 | 1.0% | 128 | $5K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 137 | $5K |
| 90686 | <1% | 258 | $4K | |
| 96160 | <1% | 159 | $3K | |
| 99000 | <1% | 118 | $3K | |
| 90680 | <1% | 136 | $2K | |
| 90677 | <1% | 89 | $2K | |
| 90744 | <1% | 130 | $2K | |
| 90633 | <1% | 128 | $2K | |
| 90656 | <1% | 120 | $2K | |
| 90619 | <1% | 122 | $2K | |
| 99382 | <1% | 20 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 53 | $2K |
| 90716 | <1% | 110 | $2K | |
| 99381 | <1% | 19 | $2K | |
| 90707 | <1% | 106 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 100 | $2K |
| 90670 | <1% | 71 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 30 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 55 | $1K |
| 90621 | <1% | 56 | $935.76 | |
| 90715 | <1% | 51 | $785.37 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 36 | $672.95 |
| 90713 | <1% | 43 | $651.69 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 46 | $580.33 |
| D1206 | Topical application of fluoride varnish | <1% | 15 | $390.00 |
| 99173 | <1% | 53 | $373.67 | |
| 90700 | <1% | 16 | $217.23 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.